CraigEColeMD

PubMed

• Y90 ibritumomab tiuxetan with maintenance rituximab as initial therapy for high tumor burden follicular lymphoma: A Wisconsin Oncology Network study.
  Thorhildur K, Chang JE, Eickhoff JC, Werndli JE, Kirby RA, Peterson CG, Cole CE, Go RS, Kahl BS> ;J. Clin. Oncol.. 2011-05-20
• Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
  Witzig TE, Wiernik PH, Moore T, Reeder C, Cole C, Justice G, Kaplan H, Voralia M, Pietronigro D, Takeshita K, Ervin-Haynes A, Zeldis JB, Vose JM> ;J. Clin. Oncol.. 2009-11-10
• Efficacy of lenalidomide oral monotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma: Final results of NHL-001.
  Witzig TE, Wiernik PH, Moore T, Reeder C, Cole C, Justice G, Kaplan H, Voralia M, Pietronigro D, Vose JM> ;J. Clin. Oncol.. 2009-05-20
• Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
  Wiernik, P.H., Lossos, I.S., Tuscano, J.M., Justice, G., Vose, J.M., Cole, C.E., Lam, W., McBride, K., Wride, K., Pietronigro, D., Takeshita, K., Ervin-Haynes, A., Zel...> ;J Clin Oncol. 2008 Oct 20
• Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells.
  Podar, K., Tai, Y., Cole, C.E., Hideshima, T., Sattler, M., Hamblin, A., Mitsiades, N., Schlossman, R.L., Davies, F.E., Morgan, G.J., Munshi, N.C., Chauhan, D., Anders...> ;J Biol Chem. 2003 Feb 21
• Join now to see all